Canadian Journal of Gastroenterology (Jan 2011)

Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada)

  • Robert P Myers,
  • Curtis Cooper,
  • Morris Sherman,
  • Richard Lalonde,
  • Helga Witt-Sullivan,
  • Magdy Elkashab,
  • Paul Harris,
  • Rob Balshaw,
  • Christopher Usaty,
  • Paul J Marotta

DOI
https://doi.org/10.1155/2011/698780
Journal volume & issue
Vol. 25, no. 9
pp. 503 – 510

Abstract

Read online

BACKGROUND: In patients chronically infected with the hepatitis C virus (HCV), it is not established whether viral outcomes or health-related quality of life (HRQoL) differ between individuals treated at academic or community centres.